The Role of CircDENND4C in Epithelial Ovarian Cancer
NCT06617585 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2024-09-27
Summary
circular RNAs (circRNAs), a newly discovered type of endogenous noncoding RNAs \[8\], are involved in the regulation of various biological functions. They act by sponging off certain microRNAs (miRNAs) and play a role in the pathogenesis of many diseases, including cancers \[9-11\]. In addition, circRNAs are not com- monly degraded by RNA enzymes present in body flu- ids \[8\], and most of them possess expression specificity at the tissue, cell, and developmental stage level \[12,13\]. Thus, they can be ideal clinica
Conditions
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-12-01
- Primary Completion
- 2028-02-02
- Completion
- 2028-10-01
More Related Trials
-
Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire
NCT03614689 ·Status: ACTIVE_NOT_RECRUITING
-
Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning.
NCT06584630 ·Status: ACTIVE_NOT_RECRUITING
-
Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer
NCT00155896 ·Status: UNKNOWN
-
Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer
NCT01187602 ·Status: UNKNOWN
-
Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer
NCT01344837 ·Status: COMPLETED
-
Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer
NCT01150682 ·Status: UNKNOWN
-
Circulating Lymphatic Progenitor Cell and Lymph Node Metastasis
NCT01268956 ·Status: UNKNOWN
-
Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or Recurrent Ovarian Cancer Patients With Germline Mutation.
NCT05458973 ·Status: UNKNOWN
-
Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers
NCT02638402 ·Status: UNKNOWN
-
Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the "Massive Parallel Sequencing" on Circulating Tumor DNA
NCT04104633 ·Status: COMPLETED ·Phase: NA
-
Retrospective Study of Ovarian Cancer Patients With Brain Metastasis
NCT01258881 ·Status: UNKNOWN
-
LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer
NCT02668913 ·Status: COMPLETED ·Phase: NA
-
Endometrial Cancer and Array CGH
NCT02833896 ·Status: COMPLETED
-
NANOTECH RCC Biomarkers
NCT02923284 ·Status: COMPLETED
-
Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker
NCT05763511 ·Status: RECRUITING
-
Biomarkers in Samples From Patients With Endometrial Cancer
NCT01199250 ·Status: WITHDRAWN
-
Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer
NCT03622385 ·Status: COMPLETED
-
Analysis of miRNA Expression in Endometrial Cancer
NCT04845425 ·Status: UNKNOWN
-
Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy
NCT06290856 ·Status: TERMINATED
-
Chromosomal Instability in Ovarian Cancer
NCT05310357 ·Status: UNKNOWN
-
Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
NCT00900289 ·Status: UNKNOWN
-
Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
NCT06893861 ·Status: RECRUITING
-
Characterizing the Cross-sectional Approach to Investigate the Prevalence of Tissue BRCA1/2 Mutations in Newly Diagnosed Advanced Ovarian Cancer Patients
NCT04222465 ·Status: COMPLETED
-
ctDNA Methylation for Epithelial Ovarian Cancer
NCT05801263 ·Status: RECRUITING
-
miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi
NCT01444560 ·Status: COMPLETED